KIP1 is known as a regulator of cellular differentiation and apoptosis in human cancer cells. We have previously reported that human chronic myeloid leukemia (CML) KU812 and K562 cells show inhibited cellular proliferation in response to treatment with activin A, a member of TGF-ß superfamily. Apoptosis and erythroid differentiation can be induced in KU812 and K562 cells, respectively. We report herein that activin A induced the expression of p27 KIP1 in CML cells along with the induction of cellular differentiation and apoptosis. There are putative binding sequences of erythroid-related transcription factor GATA-1 in the promoter region of the human p27 KIP1 gene. Expression of GATA-1 protein in activin A-treated KU812 and K562 cells showed dissimilar regulation in these two cell lines. Induction of p27 KIP1 was commonly observed, but it did not correspond to the expression levels of GATA-1 in either line of activin Atreated CML cells. In addition, ERK protein was rapidly and transiently activated with activin A in both types of CML cells, suggesting that phosphorylation of ERK is required for activin A signaling in CML cells. These results indicate that both p27 KIP1 induction and regulation of GATA-1 play essential roles in activin A-induced erythroid differentiation and apoptosis.
Introduction
Cyclin-dependent kinase (cdk) inhibitors are known to be involved in the control of cellular differentiation, proliferation, and apoptosis (1) . TGF-ß superfamily cytokines including TGF-ß, activin A, and bone morphogenetic protein (BMP) are also known to be related to and regulate the diverse cellular responses (2) . There have been many studies connecting the TGF-ß superfamily with the regulation of cdk inhibitors, and with the induction of cellular differentiation and apoptosis (3, 4) . It has been reported that p21 CIP1/WAF1 is associated with myeloid differentiation via transcriptional activation by p53, c-Jun, and TGF-ß (5-11). p21 CIP1/WAF1 and p15 INK4 are both activated by TGF-ß; however, there is no direct evidence of a relationship between the cellular differentiation and the p21 CIP1/WAF1 regulation by TGF-ß. p27 KIP1 is also known to induce apoptosis and to behave as a target during cellular differentiation (13, 14) . Up-regulation of p27 KIP1 was observed in the differentiation of various cells including osteoclast, neuron, myeloid, and erythroid cells (15) (16) (17) (18) (19) . For TGF-ß signaling, p27 KIP1 and p15 INK4 coordinate their inhibitory interactions with cdk4 and cdk2 (20) . In contrast, neutralization of autocrine TGF-ß increased p27 KIP1 and affected the differentiation states of human primitive progenitor cells in a cell cycle-independent manner (21) .
Although p27
KIP1 plays important roles in cellular differentiation and apoptosis (22) , the regulation of this molecule has not been investigated in detail.
We have previously reported that activin A, a commitment factor in erythroid differentiation, induces apoptosis and differentiation in human CML cells (23) . In this study, we examined the role of p27 KIP1 in activin A-induced differentiation and apoptosis in CML cells.
Materials and methods
Cells and cytokine. Human CML cell lines (KU812 and K562 cells) were obtained from the Japanese Cancer Research Resources Bank (JCRB; Tokyo, Japan) and were maintained in RPMI-1640 medium (Sigma Chemical Co., St. Louis, MO) with 10% fetal bovine serum (FBS, Gibco-BRL, Gaithersburg, MD), 100 U/ml penicillin, and 100 mg/ml streptomycin (Sigma) in a humidified atmosphere with 5% CO 2 . Recombinant human activin A was kindly provided by were fractionated in 12.5% SDS-polyacrylamide gel prior to transfer to the membrane (Immobilion-P membrane, Millipore, Bedford, MA) using the standard protocol. For the analysis of Rb protein, we used 6% SDS-polyacrylamide gel. Membranes were blocked overnight with 10% defatted milk in PBS containing 0.1% Tween-20 (PBS-T) or in 25 mM TBS containing 0.1% Tween-20 (TBS-T) at 4˚C. Antibodies were used at 1:300-2500 dilution in 0-10% defatted milk in PBS-T or in TBS-T for 1 h at 25˚C. Subsequently, membranes were incubated with a second antibody conjugated with horseradish peroxidase (HRP) using 1:1000-3000 dilution in 10% defatted milk. Antibody binding was detected by using an enhanced chemiluminescence kit for Western blot detection with Hyper ECL (Amersham, Buckinghamshire, UK). Blots were stained with Coomassie brilliant blue and confirmed to contain an equal amount of protein extract on each lane.
Antibodies. Antibodies used in this study were: anti-cdk4, 
Results
Expression of cell cycle-associated proteins. Levels of cdk (cdk2 and cdk4) and cyclin D3 in activin A-treated KU812 cells were all down-regulated after 12 to 48 h of treatment (Fig. 1) . Expression of cyclin E protein was increased in 0.5 to 12 h with treatment of activin A, but the levels were returned to basal level after 24-h stimulation (Fig. 1) . Phosphorylation of Rb protein, which was reported to be involved in the development of mature erythrocytes (19, 24) , was dephosphorylated after 48-h exposure to activin A (Fig. 1) . Expression of cyclin D1, D2, p15
INK4 , and p21 CIP1/WAF1 did not change during the treatment with activin A (data not shown).
Cell cycle analysis. KU812 cells were incubated with activin A (50 ng/ml) for various periods of times (0-96 h), and then cells were analyzed in terms of cell cycle distribution by means of flow cytometry. Cultivation of activin A (50 ng/ml) did not induce cell cycle arrest of KU812 cells (data not shown). At 24 h after treatment, an increase was observed in the fraction of hypodiploid cells, which indicated that these cells had undergone apoptosis (data not shown). These results suggest that activin A induced apoptosis in a cell cycle-independent manner.
Expression of p27 KIP1 protein in activin A-treated CML cells. To address the mechanism of activin A-induced apoptosis and erythroid differentiation in CML cells, we next examined the expression of p27
KIP1 protein in activin A (50 ng/ml)-treated cells. Interestingly, p27 KIP1 protein was induced and increased in both KU812 and K562 cells in a time-dependent manner (Fig. 2) , suggesting that p27 KIP1 is involved in the signaling pathway of activin A.
Expression of GATA-1 protein in activin A-treated CML cells. We searched for the human p27
KIP1 promoter region using GenBank database analysis and found that there were several putative binding sequences of c-Myb, Sp1, p300, CRE-BP1/c-Jun, and GATA-1. Activin A induced erythroid differentiation of K562 cells (23) ; therefore, we investigated the expression of erythroid-related transcription factor GATA-1 in both lines of activin A-treated CML cells. In KU812 cells, two forms of GATA-1 (47 kDa and 40 kDa) (25) were both degraded, but cleaved forms (30 kDa and 16 kDa) (26) were newly produced (Fig. 3) . In contrast, 47 kDa and 40 kDa forms of GATA-1 were both up-regulated during the treatment with activin A, but we did not detect cleaved forms in K562 cells (Fig. 3) .
Activin A-induced ERK phosphorylation in CML cells. We commonly observed the induction of p27
KIP1 by activin A treatment in both KU812 and K562 CML cells (Fig. 2) , although the expression pattern of GATA-1 is accepted for distinct regulation (Fig. 3) . It has been reported that phosphorylation levels of ERK are associated with the modulation of p27 KIP1 expression and erythroid differentiation (27) (28) (29) , so we examined the phophorylation state of ERK in activin Atreated CML cells. In both CML cells, ERK protein was rapidly and transiently up-regulated at 5 min for KU812 cells, and 5 to 10 min for K562 cells, respectively (Fig. 4) . These results suggest that phosphorylation of ERK and the induction of p27 KIP1 protein are necessary for inducing apoptosis and erythroid differentiation in activin A-treated CML cells.
Discussion

p27
KIP1 induction is involved in cells undergoing differentiation in various types of cells (16, 24) , and overexpression of this molecule induces apoptosis of cancer cells (13) . We have previously shown that activin A, a member of the TGF-ß superfamily, induced growth inhibition of KU812 and K562 human CML cells (23) . Activin A treatment induced apoptosis in KU812, but it induced erythroid differentiation in K562 cells. In this study, we found that p27 KIP1 induction was associated with both events; therefore, we further examined the relationship between the expression of p27 KIP1 and activin A-induced apoptosis and cellular differentiation. In the TGF-ß signaling pathway, p21
CIP1/WAF1 and p15 INK4 were both transactivated through coactivator p300CREB-binding protein (30) , and p21 CIP1/WAF1 promoter was activated by Smads, which cooperate with Sp1 (8) . Using the GenBank database analysis system, we found that the human p27 KIP1 promoter region has several putative sites of c-Myb, Sp1, p300, CRE-BP1/c-Jun, but not Smads. In addition, the erythroid-related transcription factor GATA-1 was also involved in the promoter region of p27 KIP1 . Analysis of GATA-1 protein showed the distinct regulation of activin A-treated KU812 and K562 CML cells. Accumulating evidence exists on the regulation of erythropoiesis by caspases (31, 32) , including caspase-mediated cleavage of GATA-1 (26) . Our previous study showed that activin A-induced apoptosis in KU812 cells preceded via the activation of caspase-3 and caspase-9, and we predicted that the apoptotic signal is preceded by a differentiation signal in activin A-treated KU812 cells (23) . Furthermore, co-stimulation with activin A and erythropoietin, a survival factor for erythroid cells and a downstream target of GATA-1 promoter (33, 34) , overrode activin A-induced apoptosis and stimulated erythroid differentiation in KU812 cells (23) . Although the GenBank database analysis did not show the putative Smad binding site in the human GATA-1 promoter region, there have been many studies on the regulation of erythropoiesis by the TGF-ß superfamily (35) (36) (37) (38) (39) . In addition, expression of GATA-1 also activates the induction of several erythroid-related genes (40) . These results suggest that GATA-1 may be one of the key molecules for the activin Ainduced erythroid differentiation signal.
Induction of p27 KIP1 by activin A, but not GATA-1, was commonly observed in both KU812 and K562 CML cells. Recent studies have reported that the Ras/MAP kinase pathway is closely related to the regulation of cdk inhibitors (7, 12) or erythroid differentiation (28, 29) . Additionally, the Ras/MAP kinase pathway is predominantly required for the stimulation of p21
CIP1/WAF1 by TGF-ß (7). In activin A-treated KU812 and K562 cells, ERK protein was rapidly and transiently upregulated. Although more direct evidence would be necessary to clarify the relationship between ERK phosphorylation and p27 KIP1 induction in activin A-treated cells, our observation might have an important implication for the activin A signaling pathway related to erythroid differentiation in CML cells. In addition, the induction or degradation of GATA-1 may be a deciding factor in the fate of cells with respect to apoptosis or differentiation in the activin A signaling pathway. 
